DJIA 17,266.39 75.02 0.44%
NASDAQ 4,627.16 -10.84 -0.23%
S&P 500 2,002.66 0.50 0.02%
market minute promo

Celgene (NASDAQ: CELG)

118.92 -0.05 (-0.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $119.03 0.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $119.58
Previous Close $118.97
Daily Range $116.55 - $119.99
52-Week Range $66.85 - $124.60
Market Cap $95.0B
P/E Ratio 62.29
Dividend (Yield) $0.00 (0.0%)
Volume 2,037,876
Average Daily Volume 6,021,828
Current FY EPS $3.26

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

Celgene Corp.'s Fourth-Quarter Earnings Predict Jaw-Dropping Growth: Here's Why

Although Celgene Corp. only narrowly beat consensus in the fourth-quarter, management is predicting jaw-dropping levels of growth going forward. Here's what investors need to know.

Celgene Q4 Earnings & Revenues In Line, Revlimid Sales Up - Analyst Blog

Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog

Is Celgene’s Outlook Good Enough for Investors?

Celgene (CELG) Q4 2014 Results - Earnings Call Webcast

Synageva Starts Dosing in Phase I/II Study for Sanfilippo B - Analyst Blog

Pre-Market Earnings Report for January 29, 2015 : CELG, COP, EPD, ABT, OXY, CL, F, EMC, DOW, TMO, T

Pre-Market Earnings Report for January 29, 2015 : CELG, COP, EPD, ABT, OXY, CL, F, EMC, DOW, TMO, TWC, PSX

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Short Sellers Starting to Gang Up on Biotech

Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog

See More CELG News...

CELG's Top Competitors

CELG $118.92 (-0.04%)
Current stock: CELG
AMGN $154.19 (-0.29%)
Current stock: AMGN
GILD $102.98 (0.52%)
Current stock: GILD
$0.00 (0.00%)
Current stock: